
Heron Therapeutics, Inc.
USD0.43
-0.00 (-0.18%)
CEO
Craig Alexander Collard
IPO Date
1987-08-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.44
Prev. Close
$0.44
Day Low
$0.43
Day High
$0.45
52W Low
$0.38
52W High
$2.30
Market Cap
$0.07B
Volume
1.31M
Heron Therapeutics Announces Publication Showing Reduction of Pain and Opioid Use Compared to Bupivacaine in Patients 65 and Older with ZYNRELEF™